461 related articles for article (PubMed ID: 32133940)
1. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
2. Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
[TBL] [Abstract][Full Text] [Related]
3. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
4. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of post-transplant malignancy and mortality in transplant tourists: a nationwide population-based cohort study in Taiwan.
Chung MC; Wu MJ; Chang CH; Muo CH; Yu TM; Ho HC; Shu KH; Chung CJ
Medicine (Baltimore); 2014 Dec; 93(29):e344. PubMed ID: 25546686
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
[TBL] [Abstract][Full Text] [Related]
8. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
9. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
10. A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.
Chen CH; Shu KH; Ho HC; Cheng SB; Lin CC; Wei HJ; Lin CH; Chang SN; Wu MJ
Transplant Proc; 2014 May; 46(4):1032-5. PubMed ID: 24815120
[TBL] [Abstract][Full Text] [Related]
11. Emergency Department Visits After Kidney, Liver, and Heart Transplantation in a Hospital of a University in Turkey: A Retrospective Study.
Mıhçıokur S; Doğan G; Kocalar G; Erdal R; Haberal M
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):264-269. PubMed ID: 30777572
[TBL] [Abstract][Full Text] [Related]
12. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.
Collett D; Mumford L; Banner NR; Neuberger J; Watson C
Am J Transplant; 2010 Aug; 10(8):1889-96. PubMed ID: 20659094
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
15. Risk of incident gout in kidney transplant recipients: A retrospective cohort study.
Simbolon FR; Lee SS; Tsai YC; Tsai WC; Lin GT; Tung YC; Tu HP
Int J Rheum Dis; 2018 Nov; 21(11):1993-2001. PubMed ID: 30338664
[TBL] [Abstract][Full Text] [Related]
16. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
[No Abstract] [Full Text] [Related]
17. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
18. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
[TBL] [Abstract][Full Text] [Related]
20. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]